Crown Bioscience Inc.
Crown Bioscience Announces Merger with JSR Corporation
SAN DIEGO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announced yesterday that they will merge with and become a fully owned subsidiary of the JSR Corporation, headquartered in Tokyo, Japan. The merger produces a fully integrated suite of innovative solutions to support researchers through every stage of drug and diagnostic development - from early research through manufacturing.
The strategic merger integrates Crown Bioscience's leading translational technology platform providing drug target validation, efficacy testing and patient response characterization with JSR's in vitro diagnostic (IVD) solutions, GMP manufacturing capabilities and worldwide distribution networks.
"We are excited to join the JSR family of companies through this innovation-driven strategic partnership," said Dr. Jean-Pierre Wery, Crown Bioscience's Chief Executive Officer. "Crown Bioscience's core competencies in preclinical and translational research combined with JSR's global footprint, diagnostic solutions and manufacturing capabilities will provide a fully integrated solution to help biopharmaceutical companies get drugs and diagnostics to market more efficiently."
The completion of the merger is expected to close before the end of the second quarter of 2018.
About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
Crown Bioscience Inc.
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
SharesPost15.8.2018 15:01 | pressemeddelelse
Huobi Joins GLASS Network and Invests in SharesPost
Corel14.8.2018 15:12 | pressemeddelelse
Pinnacle Studio 22 Ultimate Amps Up Video Editing with New Pro-inspired Features
Meltwater14.8.2018 15:01 | pressemeddelelse
Meltwater launches data science platform Fairhair.ai to tame real-time market signals found in world’s online data
Crown Bioscience14.8.2018 14:01 | pressemeddelelse
CrownBio Expands Genetically Engineered Model Selection Via Strategic Alliance with Shanghai Model Organisms Center (SMOC)
Mash Group Oyj13.8.2018 08:01 | pressemeddelelse
Mash Group Plc reports interim unaudited financials, H1 2018 ended 30th June 2018
ATPCO13.8.2018 06:01 | pressemeddelelse
ATPCO Awarded Patent for Cacheless Airline Ticket Pricing Model
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum